Target
PIM1
2 abstracts
Abstract
Genomic profiling in a subgroup analysis of patients (pts) with diffuse large B-cell lymphoma (DLBCL) and extranodal (EN) sites of involvement in the phase 3 Pola-R-CHP versus R-CHOP (POLARIX) study.Org: Centre Henri-Becquerel and University of Rouen, University Hospital Münster, M.D. Anderson Cancer Center, Charles University General Hospital, University of Montpellier,
Abstract
Characterizing the role of PIM kinases in the prostate tumor immune microenvironment.Org: The University of Arizona Cancer Center, Tucson, AZ, Caris Life Sciences, Irving, TX, Phoenix, AZ, Karmanos Cancer Institute,